Forget buy-to-let! I’d buy these 2 FTSE 100 stocks to retire early

I think these two FTSE 100 (INDEXFTSE:UKX) shares could offer improving growth outlooks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The outlook for the buy-to-let industry may be more positive following the general election. Fears surrounding a Jeremy Corbyn-led government and potential changes to taxation may mean that house prices make gains in the short run.

However, in the long run, the FTSE 100 could outperform buy-to-let investments. It appears to offer superior value for money, greater diversity and a range of stocks with sound growth strategies.

With that in mind, here are two FTSE 100 shares that could deliver impressive long-term total returns. They could help to bring your retirement date a step closer.

AstraZeneca

Recent updates from pharma stock AstraZeneca (LSE: AZN) have provided evidence of the scale of its turnaround. While in previous years it has struggled to generate top- and bottom-line growth, its sales and profitability are now growing at double-digit rates. This trend could continue over the medium term as the business benefits from the major investment it has made in its pipeline over recent years.

Risks facing UK investors may have subsided following the recent general election. However, global growth uncertainties remain in place. For example, political risk in the US and China may continue to be high in 2020, while tariffs could act as a drag on global GDP growth. Therefore, AstraZeneca’s defensive characteristics could help it to outperform many of its FTSE 100 peers. Its reduced dependency on the wider economy’s performance may mean that it becomes more popular among investors.

As such, now could be the right time to buy a slice of the company. Its improving financial performance and increasing favour among investors may mean that it outpaces house price growth in the long run.

Bunzl

One FTSE 100 share that is being negatively impacted by an uncertain global macroeconomic outlook is Bunzl (LSE: BNZL). The international distribution and services company recently released a trading update that showed the slowing sales trend from earlier in 2019 has continued.

For example, in its third quarter, the company reported a rise in sales at constant exchange rates of just 0.5%. When the impact of acquisitions is excluded, its sales declined by 1%.

Looking ahead, Bunzl has an active acquisition pipeline. It has already spent £100m on acquisitions this year, and is likely to continue to add new businesses to its portfolio over the medium term. They could catalyse its financial performance and help to offset an uncertain trading period for the business.

With a solid track record of growth that includes five continuous years of increasing earnings, Bunzl could offer long-term growth potential. Following its 12% share price decline in the last year, now could be the right time to buy a slice of it while it trades on a lower valuation. It may fail to recover significantly in the short run, but could offer turnaround potential in the coming years.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young black colleagues high-fiving each other at work
Investing Articles

Why now could be the time to buy these recovering FTSE 100 growth shares!

Royston Wild is building a list of the FTSE's greatest shares to buy today. Here are two he thinks could…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

My Stocks and Shares ISA has two giant weeds in it. Should I pull them out?

This writer has two massive losers inside his Stocks and Shares ISA portfolio. What's gone wrong? And is it time…

Read more »

Mature black couple enjoying shopping together in UK high street
Investing Articles

7.5% dividend yield! 2 cheap passive income stocks to consider for a £1,500 payout

Royston Wild describes how large investment in these passive income stocks could provide a four-figure cash payout this year.

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

Billionaires are selling Nvidia stock! I’d rather buy this AI share instead

With billionaire investors now banking profits in Nvidia stock, our writer considers an AI share that still looks to be…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

3 shares that could soar as the UK stock market wakes from its slumber

The UK stock market is on fire at the moment. If it keeps rising from here, Edward Sheldon reckons these…

Read more »

View of Tower Bridge in Autumn
Investing Articles

The FTSE 100 is on fire! 2 top shares I’d still snap up

FTSE 100 shares as a whole might be setting records on a daily basis this month, but that doesn't mean…

Read more »

Young Black man sat in front of laptop while wearing headphones
Investing Articles

£11,000 in savings? Here’s how I’d aim to turn that into a £15,080-a-year second income

Buying dividend shares is how this Fool continues to build up his second income. With a lump sum of savings,…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Value Shares

This undervalued FTSE 250 stock could do well in the AI boom

As chip producers build manufacturing plants and data companies construct data centres, this hidden gem in the FTSE 250 could…

Read more »